Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 65
Selected: 0
NCT IDTitle
NCT04028492Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis
NCT03568331Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE)
NCT04652882Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD)
NCT04819776Evaluation of Efficacy and Safety of Iloperidone in the Acute Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder
NCT01402076A Study to Assess the Effect Tasimelteon on the Cytochrome P450 3A4 and 2C8 Enzymes in Healthy Subjects
NCT05344365A Study to Evaluate Iloperidone for the Treatment of Parkinson's Disease Psychosis
NCT01578057Evaluation of the Pharmacodynamic and Pharmacokinetic Interactions of Tasimelteon and Ethanol
NCT04353401WGS Analysis of COVID-19 Positive Patients
NCT01526746Pharmacokinetics of Tasimelteon in Subjects With Renal Impairment and Matched Control Subjects With Relatively Normal Renal Function
NCT05648591Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
NCT04326426ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection
NCT03838926Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic Malignancies
NCT06296966A Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye
NCT06323655Evaluation of Next-Day Residual Effects of Tasimelteon Compared With Placebo and Active Control in Healthy Subjects
NCT02970968Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis
NCT01919944Study of Itch Control by VLY-686 in Healthy Volunteers After Intradermal Injections of Substance P
NCT03772340Motion Sifnos: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness
NCT00548340VEC-162 Study in Adult Patients With Primary Insomnia
NCT03373201Evaluating the Effects of Tasimelteon vs. Placebo on Jet Lag Type Insomnia
NCT01218789Safety Study of Tasimelteon for Treatment of Non-24-Hour-Sleep-Wake Disorder in Blind Individuals With No Light Perception
NCT04127058Evaluating a New Iloperidone Titration Scheme in Bipolar I Disorder or Schizophrenia
NCT06701396Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) and the CRY1Δ11 Variant
NCT01195558Patient Registry of Blind Subjects With Sleep-related Problems
NCT01495169Tolerability and Pharmacokinetics of Iloperidone in Adolescent Patients
NCT05572281Bioequivalence Study Between Tasimelteon Capsule Formulation and Liquid Suspension Formulation in Healthy Volunteers
NCT02004041Proof of Concept of VLY-686 in Subjects With Treatment-Resistant Pruritus Associated With Atopic Dermatitis
NCT00467441VSF-173 Study in Healthy Adult Volunteers for Treatment of Induced Excessive Sleepiness
NCT03291041A Proof of Concept Study to Evaluate the Effects of Tasimelteon and Placebo in Travelers With Jet Lag Disorder
NCT01477619Effects of Smoking, Age and Body Size on Pharmacokinetics, Safety and Tolerability on Tasimelteon in Healthy Subjects
NCT05903924Motion Serifos: a Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness
NCT04712734A Study to Evaluate Iloperidone Long-acting Injection (LAI) for the Treatment of Schizophrenia
NCT01429116Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception
NCT02413918Iloperidone in Mixed States of Bipolar Disorder
NCT01637636Pharmacokinetics of Tasimelteon Alone and in Combination With a CYP3A4 Inhibitor, Ketoconazole, or a CYP3A4 Inducer, Rifampin.
NCT06138613Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness
NCT02130999Open Label Study to Assess the Absolute Bioavailability of Tasimelteon (HETLIOZ™)
NCT06803290Food Effect Study of VHX-896 in Healthy Volunteers
NCT02231008Evaluating the Effects of Tasimelteon vs Placebo on Sleep Disturbances in SMS
NCT02651714Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis
NCT04140695Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2)
NCT05922995The Effects of Tasimelteon in Participants With REM Behavior Disorder (RBD)
NCT04849559Effects of Tradipitant on Satiation, Gastric Volume, Gastric Accommodation, and Gastric Emptying in Healthy Volunteers
NCT01348100Safety, Tolerability, and Pharmacokinetics of Iloperidone Depot in Schizophrenic Patients
NCT01540500Pharmacokinetics of Tasimelteon Alone and in Combination With CYP1A2 Inhibitor, Fluvoxamine
NCT01163032Efficacy and Safety of Tasimelteon Compared With Placebo in Totally Blind Subjects With Non-24-Hour Sleep-Wake Disorder
NCT02560103An Observational Study to Investigate the Effects of Rapid Transmeridian Travel
NCT06804603A Study to Measure the Effects of Using Tradipitant on Nausea and Vomiting After GLP-1R Agonist Use
NCT00254202Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia
NCT04474990Single-Patient Expanded Access Protocol for Tradipitant In A Single Patient With Gastroparesis
NCT01271387Pharmacokinetics of Tasimelteon in Subjects With Mild or Moderate Hepatic Impairment